ISCONOVA ACQUIRED BY US VACCINE COMPANY NOVAVAX
APRIL 1 – JUNE 30, 2013
· Consolidated net sales were SEK 5.7 M (5.3)
· Operating result amounted to a loss of SEK 11.9 M (loss: 8.2)
· Net result amounted to a loss of SEK 11.7 M (loss: 8.3)
· Result per share before and after dilution amounted to a loss of SEK 0.94 (loss: 1.99)
Help employers find you! Check out all the jobs and post your resume.
